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Abstract
The action of 2-aminoethoxydiphenyl borate (2-APB) on Ca2+ signalling in HeLa cells and cardiac myocytes was investigated. Con-
sistent with other studies, we found that superfusion of cells with 2-APB rapidly inhibited inositol 1,4,5-trisphosphate (InsP3)-mediated
Ca2+ release and store-operated Ca2+ entry (SOC). In addition to abrogating hormone-evoked Ca2+ responses, 2-APB could antagonise
Ca2+ signals evoked by a membrane permeant InsP3 ester. 2-APB also slowed the recovery of intracellular Ca2+ signals consistent with
an effect on Ca2+ ATPases. The inhibitory action of 2-APB on InsP3 receptors (InsP3Rs), SOC channels and Ca2+ pumps persisted for
several minutes after washout of the compound. Application of 2-APB to unstimulated cells had no effect on subsequent Ca2+ responses
suggesting that it has a use-dependent action. Mitochondria in cells treated with 2-APB showed a rapid and slowly reversible swelling.
2-APB did not cause the mitochondria to depolarise, but it reduced the extent of mitochondrial calcium uptake. Although 2-APB has
been demonstrated not to affect voltage-operated Ca2+ channels or ryanodine receptors, we found that it gave a concentration-dependent
long-lasting inhibition of Ca2+ signalling in electrically-stimulated cardiac myocytes, where InsP3Rs and SOC channels do not play a
significant role. Our data suggest that 2-APB has multiple cellular targets, a use-dependent action, is difficult to reverse and may affect
Ca2+ signalling in cell types where InsP3 and SOC are not active.
© 2003 Elsevier Science Ltd. All rights reserved.
Keywords: 2-Aminoethoxydiphenyl borate; Ca2+ signalling; InsP3
1. Introduction
Ca2+ release from intracellular stores is mediated by
a variety of intracellular messengers and channels [1].
One widely-expressed family of intracellular Ca2+ chan-
nels is activated by the lipid-derived messenger, inositol
1,4,5-trisphosphate (InsP3). Binding of InsP3 to its recep-
tors (InsP3Rs) mobilises Ca2+ from the lumen of organelles
such as the endoplasmic/sarcoplasmic reticulum (E/SR)
and Golgi [2,3]. At present, there is a paucity of available
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antagonists that can be used to probe the contribution of
InsP3Rs in cellular responses. One of the most commonly
used InsP3R antagonists is heparin. This compound is lim-
ited because it has multiple actions including uncoupling
G-protein signalling and activating ryanodine receptors
(RyRs) (for reviews see [4,5]). Furthermore, heparin is not
membrane permeant, and therefore has to be injected or
infused into cells from micropipettes, although it has been
suggested that low molecular weight heparin species may
cross the plasma membrane and thus inhibit InsP3Rs within
intact cells [6]. Xestospongins, which were first described as
relatively specific membrane-permeant InsP3R antagonists
by Pessah and colleagues [7], have been employed many
times to prove whether InsP3Rs are involved in particular
responses. Although there are many examples of xestospon-
gin inhibiting Ca2+ signalling, its mechanism of action
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has not been fully elucidated. Furthermore, xestospongin is
expensive, often slow to act and has not been universally
successful (e.g. [8]).
2-Aminoethoxydiphenyl borate (2-APB) was introduced
as an InsP3R antagonist by Maruyama et al. [9]. It has sub-
sequently been used in many studies to probe the contri-
bution of InsP3Rs in the generation of cellular Ca2+ sig-
nals (for review see Ref. [10]). The initial study of 2-APB
showed that it evoked a concentration-dependent inhibition
of InsP3-induced Ca2+ release from mouse cerebellar mem-
branes. The mechanism by which 2-APB inhibits InsP3R
activity is unclear, although it does not diminish InsP3 bind-
ing [9,11–13].
Unlike xestospongins, which can inhibit both InsP3Rs and
RyRs, 2-APB may not have any action on the latter type
of channel. It did not affect caffeine-activated Ca2+ release
from striated muscle vesicles [9] or toad sinus venosus [14].
Furthermore, in smooth muscle, 2-APB inhibited contrac-
tile responses to InsP3-generating stimuli, but not those trig-
gered by KCl-induced depolarisation [9,15,16] suggesting
that there was no effect on voltage-operated Ca2+ entry or
the contractile machinery. Even though 2-APB may have
no effect on RyRs or voltage-operated Ca2+ channels, it is
clearly not entirely specific for InsP3Rs [10] and in some
cell types inhibition of InsP3-induced Ca2+ release is not
observed at all (e.g. [17]). Probably the most consistent ac-
tion of 2-APB is to block store-operated Ca2+ entry (SOC)
[10]. The inhibition of SOC is not due to action of 2-APB
on InsP3Rs [18], since it occurs in cells not expressing those
channels [19–23], or in processes that do not require func-
tional InsP3Rs such as Drosophila phototransduction [24].
Furthermore, 2-APB rapidly blocks SOC by acting at extra-
cellular sites [19,20,25]. In addition, it has been shown to in-
hibit sarco-endoplasmic reticulum Ca2+ ATPases (SERCAs)
[11,26], thus promoting the gradual release of Ca2+ stores.
Despite the lack of specificity of 2-APB, it remains a
widely-used inhibitor of intracellular Ca2+ signalling, and
it is therefore important to elucidate its intracellular targets
and mechanism of action. In the present study, we examined
the ability of 2-APB to affect Ca2+ signalling in HeLa cells
and cardiac myocytes. Although it clearly has a rapid an-
tagonistic action on InsP3-evoked Ca2+ release, it appears
to have a use-dependent action on multiple targets and is
poorly reversible.
2. Materials and methods
2.1. HeLa cell culture
HeLa cell culture was performed as described previ-
ously [27]. All experimental procedures were carried out
at room temperature (20–22 ◦C). Prior to imaging, the cul-
ture medium was replaced with an extracellular medium
(EM) containing (mM): NaCl, 121; KCl, 5.4; MgCl2, 0.8;
CaCl2, 1.8; NaHCO3, 6; d-glucose, 5.5; HEPES, 25; pH
7.3. Histamine, ATP, thapsigargin and ionomycin were ob-
tained from Sigma. All fluorescent dyes were obtained from
Molecular Probes (OR, USA). Statistics were performed
using Student’s t-test (GraphPad Prism, San Diego, CA,
USA). The InsP3 ester was made by Dr. Stuart Conway
and Professor Andrew Holmes (Department of Chemistry,
University of Cambridge, UK). Please contact the authors
for details of the synthesis.
2.2. Video imaging
Measurement of cytosolic calcium in HeLa cells was per-
formed by monitoring Fura2 fluorescence of cells adhered
to glass coverslips using either a Spex or a Perkin-Elmer
imaging system. Fura2 was loaded into the cells by incu-
bation with 2M Fura2 acetoxymethyl ester (30 min incu-
bation followed by a 30-min period for de-esterification).
For the Spex system, cells on coverslips were mounted on a
Nikon Diaphot inverted epi-fluorescence microscope. Fluo-
rescent images were obtained by alternate 40 ms excitation
at 340 and 380 nm using twin xenon arc lamps each cou-
pled to a spex monochrometer (Spex Industries Edison, NJ,
USA), with the wavelengths being switched by a rotating
chopper mirror (Glen Creston Instruments, Stanmore, UK).
Emission signals at 510 nm were collected using an inten-
sified charge-coupled device video camera (Photonics Sci-
ence, Robertson, UK) and filtered with a 200 ms time con-
stant (Spex system) prior to off-line storage for analysis us-
ing an Imagine image processing system (Synoptics, Cam-
bridge, UK) as described previously.
With the Perkin-Elmer system, a single glass coverslip
with adherent cells was mounted on the stage of a Nikon
Diaphot 300 inverted epi-fluorescence microscope coupled
to a xenon arc lamp (Nikon) light source. Fluorescence
images were obtained with alternate excitation at 340
and 380 nm, selected for using either a Sutter filter wheel
(340HT15 and 380HT15, Sutter Industries), or a Spec-
tramaster II monochrometer. Emitted light was filtered at
510 nm and collected by a cooled Astrocam digital camera.
The acquired images were stored and subsequently pro-
cessed off-line with Ultraview software (Perkin-Elmer Life
Sciences Ltd., Cambridge, UK).
2.3. Confocal microscopy of mitochondrial membrane
potential and calcium uptake
HeLa cells were loaded with tetramethyl rhodamine ethyl
ester (TMRE; 0.1M for 20 min) and a median section
through the cell was imaged with 60× (1.4 NA) objective
on a BioRad MRC1024 laser scanning confocal microscope
(LSCM) (excitation 514 nm and emission >525 nm). For mi-
tochondrial calcium uptake experiments, HeLa cells were
loaded with Rhod-2 (1M for 30 min followed by a fur-
ther 30 min for de-esterification). A median section through
the cells was imaged (images collected every 2.5 s) using a
BioRad MRC1024 LSCM (excitation 514 nm and emission
>525 nm).
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2.4. Cardiomyocyte isolation and calcium measurement
Rat atrial myocytes were isolated from male Wistar rats
by an enzymatic isolation method described earlier [28].
Single cells were kept in an EM containing (in mM):
NaCl, 135; KCl, 5.4; MgCl2, 2; CaCl2, 1; glucose, 10;
HEPES, 10; pH 7.35. All experiments were performed
at room temperature (20–22 ◦C). Cells were loaded with
4M Indo1 (30 min with Indo1/AM followed by a 30-min
de-esterification period). Whole cell fluorescence in electri-
cally paced (0.3 Hz) cells was imaged using a photometric
imaging system (Perkin-Elmer Life Sciences, Cambridge,
UK) sampling at 200 Hz. Cells were electrically paced with
a pair of field electrodes (1 Hz, 40 V, 2 ms duration).
3. Results
3.1. 2-APB inhibits InsP3-evoked Ca2+ release
To determine that 2-APB was able to enter cells and in-
hibit Ca2+ release, Fura2-loaded HeLa cells were stimulated
with a membrane-permeant InsP3 ester that directly activates
InsP3Rs following de-esterification [29,30]. The InsP3 ester
(20M) by itself typically evoked a ∼10-fold increase of
the cytosolic Ca2+ concentration (Ca2+cyt). Application of
2-APB (100M) prior to InsP3 ester completely inhibited
the Ca2+cyt elevation (Fig. 1A). 2-APB gave a similar in-
hibition of Ca2+cyt responses within cells stimulated in ex-
tracellular Ca2+-free medium (Fig. 1B). Addition of 2-APB
to cells already responding to InsP3 ester caused the rapid
decline of Ca2+cyt back to basal levels (Fig. 1C). Typically,
2-APB inhibited the InsP3 ester-induced Ca2+cyt elevation
after a delay of only a few seconds. These data suggest that
2-APB can readily enter HeLa cells and inhibit InsP3Rs.
Similar to its effects on InsP3 ester-induced Ca2+ signals,
2-APB inhibited responses evoked by the InsP3-generating
agonist histamine. The degree of inhibition was dependent
on the stimulating histamine concentration with the re-
sponses to 100, 10 and 1M histamine being reduced to
28±1, 5±1 and 3±0.1% of a control response, respectively
(Fig. 2 and data not shown). With 1 or 10M histamine,
2-APB reduced both the amplitude of Ca2+cyt increases and
also the proportion of responsive cells (Fig. 2E).
Ca2+cyt signals evoked by another InsP3-generating stim-
ulus, ATP, were also inhibited by 2-APB. However, 2-APB
appeared to have a more substantial inhibitory effect on
ATP-evoked responses than those observed with histamine,
as it completely prevented Ca2+cyt elevation by 1, 10 or
100M ATP (Fig. 3A–D and data not shown). ATP is a
weaker agonist than histamine on HeLa cells. The concen-
trations of histamine and ATP required for half-maximal
Ca2+ signals are ∼2.5 and 10M, respectively (data not
shown). However, 100M of either agonist produced similar
maximal Ca2+cyt increases (Fig. 3E). It is therefore surpris-
ing that 100M 2-APB was able to completely inhibit re-
Fig. 1. 2-APB inhibits Ca2+ signals evoked by a membrane-permeant
InsP3 ester. Panels A–C illustrate the inhibition of Ca2+cyt responses
evoked by application of membrane-permeant InsP3 ester (20M). The
InsP3 ester was applied at the time shown by the horizontal bars. For
panels A and B, 100M 2-APB was applied 2 min before the InsP3
ester, to allow for equilibration. The experiments in panels A and C
were performed with cells in Ca2+-containing extracellular medium. The
experiment in panel B was performed with cells in a nominally Ca2+-free
medium. The traces shown are from individual cells, and are typical of
the responses of at least 20 cells for each condition analysed in three
independent experiments.
sponses to a maximal ATP dose whilst sub-maximal concen-
trations of histamine (i.e. 1 and 10M) could evoke signals
(Figs. 2 and 3).
We did not investigate the effects of 2-APB concentra-
tions higher than 100M since they caused a pronounced
increase of basal Ca2+cyt, consistent with earlier reports of
SERCA inhibition [11,26]. Concentrations of 2-APB lower
than 100M produced curious effects. With maximal his-
tamine concentrations, 1 and 10M 2-APB caused inhibi-
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Fig. 2. 2-APB inhibits Ca2+ signals evoked by histamine. Panels A and C depict the normalised Ca2+cyt response of HeLa cells to three consecutive pulses
of histamine (1 min agonist application followed by a 10 min continuous wash between pulses). Panels B and D illustrate the effect of 100M 2-APB
on histamine-evoked Ca2+ responses (2-APB was added 2 min prior to the second histamine pulse, and maintained during the histamine application).
For panels A–D, the Ca2+cyt responses are shown as normalised values, calculated as a percentage of the control response (i.e. pulse 1 = 100%). The
data represent the averaged response (mean± S.E.M.) of at least 30 cells from three independent experiments for each histamine concentration. Panel E
indicates the effect of 2-APB on the proportion of cells responsive to the histamine concentrations shown. The asterisk (∗) indicates significantly different
from control (P < 0.05).
tion of the Ca2+cyt responses. With lower histamine con-
centrations, 1 and 10M 2-APB potentiated Ca2+cyt sig-
nals. For example, the Ca2+cyt response evoked by 1M
histamine was increased from 69 ± 12 nM (n = 20) to
120± 15 nM (n = 30) by concurrent application of 10M
2-APB (data not shown).
3.2. 2-APB is poorly reversible and has a ‘use-dependent’
action
The inhibition of histamine- and ATP-evoked Ca2+cyt sig-
nals by 2-APB did not fully reverse on washout of 2-APB.
Using pulsatile application of histamine (1 min application
followed by a 10 min washout), it appeared that 2-APB
(100M) not only inhibited responses when it was present,
but also decreased the amplitude of Ca2+cyt signals ob-
served with successive agonist additions (Figs. 2 and 3).
The long-lasting inhibitory effect of 2-APB only occurred
if it was applied at the same time as an InsP3-generating
agonist. If 2-APB was given by itself, it did not cause any
decrement of subsequent agonist-evoked Ca2+ signals be-
yond the normal desensitisation observed with HeLa cells
(Fig. 4). The requirement for concurrent cell stimulation for
the prolonged inhibitory effect of 2-APB is reminiscent of
the use-dependent action of other agents such as ryanodine
[31], and may suggest that it binds more readily to activated
channels.
Histamine- and ATP-evoked responses declined in the
repetitive agonist application protocol even in the absence
of 2-APB (Figs. 2 and 3). This was most likely due to the
progressive desensitisation of agonist-mediated Ca2+ sig-
nalling. However, both the acute and sustained inhibitory
effects of 2-APB were obvious and significant despite the
on-going desensitisation to agonists.
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Fig. 3. 2-APB inhibits Ca2+ signals evoked by ATP. Panels A and C depict the normalised Ca2+cyt response of HeLa cells to three consecutive pulses
of ATP (1 min agonist application followed by a 10 min continuous wash between pulses). Panels B and D illustrate the effect of 100M 2-APB on
ATP-evoked Ca2+ responses (2-APB was added 2 min prior to the second ATP pulse, and maintained during the ATP application). For panels A–D,
the Ca2+cyt responses are shown as normalised values, calculated as a percentage of the control response (i.e. pulse 1 = 100%). The data represent
the averaged response (mean ± S.E.M.) of at least 30 cells from three independent experiments for each ATP concentration. The asterisk (∗) indicates
significantly different from control (P < 0.05). Panel E shows that maximal concentrations of ATP and histamine (100M of each) evoked similar Ca2+
increases, yet 2-APB (100M) was a more potent inhibitor of ATP responses.
In addition to its inhibitory effect on InsP3-induced Ca2+
release, 2-APB has been shown to be a potent blocker of
SOC-mediated Ca2+ influx [10]. 100M 2-APB imme-
diately and completely curtailed Ca2+cyt increases due to
Ca2+ influx triggered by discharge of intracellular Ca2+
stores with thapsigargin (2M; data not shown). Simi-
lar to the effect on histamine-induced Ca2+ signals, the
inhibition of SOC did not reverse fully during a 5-min
wash period (Fig. 5A–D). Furthermore, 2-APB also had a
use-dependent effect on Ca2+ influx. If 2-APB was applied
to cells prior to stimulation with thapsigargin, it did not in-
hibit SOC-mediated Ca2+ entry (Fig. 6A and B). However,
once SOC was activated following Ca2+ store depletion,
one brief pulse of 2-APB produced a long-lasting and
substantial reduction of Ca2+ influx (Fig. 6C and D).
Another significant and long-lasting effect of 2-APB was
to decrease the rate of decline of Ca2+cyt signals. Using
the protocol shown in Fig. 5A, where SOC-mediated Ca2+
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Fig. 4. The inhibition of histamine-evoked Ca2+ signals by 2-APB is use-dependent and poorly reversible. Panels A and C depict the response of
individual HeLa cells to pulsatile application of histamine. For panel A, histamine was applied four times (1 min application and ∼10 min washout;
shown by the black bars), and 2-APB was added 1 min before and during the second histamine perfusion. Panel C depicts a similar experiment to that
in A, except that 100M 2-APB was applied to the cell in the absence of histamine. Panels B and D show the normalised data (mean ± S.E.M.) from
at least 30 cells from three independent experiments for each condition. The asterisk (∗) indicates significantly different from control (P < 0.05).
influx was triggered by pulsatile application of extracellular
Ca2+ following discharge of Ca2+ stores with thapsigargin,
it was observed that the mono-exponential rate constant for
the recovery of Ca2+cyt was decreased by 2-APB (Fig. 5E).
In addition to reducing the rate constant for decline of
Ca2+cyt for the Ca2+ pulse when it was applied, 2-APB
also reduced the recovery of Ca2+cyt for subsequent Ca2+
pulses after it had been washed out (Fig. 5E). Since the
SERCA pumps were inhibited by thapsigargin in these
experiments, the decline of Ca2+cyt recovery must be due
to inhibition of the other Ca2+ removal pathways, such as
plasma membrane Ca2+ ATPases (PMCAs) and mitochon-
dria.
Previous evidence has suggested that 2-APB can interact
with mitochondria and prevent them releasing sequestered
Ca2+, possibly by an inhibitory action on the Na+/Ca2+
exchanger [19]. We observed that 100M 2-APB caused
mitochondria to reversibly swell and change shape (Fig. 7A).
It does not cause them to depolarise (Fig. 7B), but it did
reduce the extent of Ca2+ uptake into the mitochondrial
matrix (Fig. 7C).
The prolonged inhibition of SOC may account for the fail-
ure of histamine- and ATP-evoked Ca2+cyt signals to recover
following 2-APB washout (Figs. 2 and 3). Reduction in SOC
would have prevented the Ca2+ stores from fully refilling
during the inter-stimulation interval. Consistent with this, it
was found that the amount of ionomycin-releasable Ca2+ in
the intracellular stores was decreased by 2-APB. Following
two brief histamine pulses (1 min agonist application fol-
lowed by a 10 min wash), the peak ionomycin-induced Ca2+
signal was found to be ∼60% larger than the first histamine
application (Fig. 8A). If 100M 2-APB was applied dur-
ing the second histamine pulse the subsequent ionomycin
response was decreased by ∼40% (Fig. 8B).
As mentioned above, we chose to investigate the action
of 100M 2-APB since this was the highest concentration
that did not cause a significant change of Ca2+cyt by it-
self. However, even though there was no change in Ca2+cyt,
this concentration of 2-APB did enhance loss of Ca2+ from
the intracellular Ca2+ pool. Removal of Ca2+ from medium
in which HeLa cells are bathed causes the progressive de-
pletion of the intracellular stores, probably due to passive
Ca2+ leakage and the inability of SOC to replenish the
lost Ca2+ (data not shown). 2-APB exacerbated the rate
of decline of the Ca2+ stores when cells were placed in
Ca2+ free medium (Fig. 9). After only a 1-min incuba-
tion of HeLa cells with 2-APB in a Ca2+-free medium,
the ionomycin-releasable Ca2+ pool was reduced by ∼40%.
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Fig. 5. 2-APB inhibits SOC-mediated Ca2+ influx. To activate SOC, the intracellular Ca2+ stores were discharged by incubation of cells with 2M
thapsigargin in nominally Ca2+ free medium. Panel A shows the response of HeLa cells to repetitive activation of Ca2+ influx caused by the pulsatile
re-addition of Ca2+ to the extracellular medium. Panel C depicts a similar experiment to A, except that 100M 2-APB was applied 1 min before and
during the second Ca2+ pulse. Panels B and D summarise data from the experiments illustrated in panels A and C (mean± S.E.M. for at least 30 cells
from three independent experiments for each condition). Panel E depicts the averaged first-order rate constant for the recovery of the Ca2+cyt signals
following the second and third Ca2+ pulses for control cells (open columns), cells in the presence of 2-APB (grey column) and following 2-APB washout
(shaded column). The data were obtained by fitting the decline of the Ca2+ signals after removal of extracellular Ca2+ to a single-exponential decay
curve. The asterisk (∗) indicates significantly different from control (P < 0.05).
This increased loss of Ca2+, above the passive rate of Ca2+
depletion, was maintained for up to 30 min (Fig. 9), by which
time the ionomycin induced Ca2+ signals were small in
amplitude.
3.3. 2-APB inhibits cardiac excitation–contraction
coupling
Data from several studies have demonstrated that 2-APB
does not affect voltage-activated Ca2+ channels or RyRs
[10]—key components of cardiac excitation–contraction
coupling (EC-coupling). However, we observed that 2-APB
caused concentration-dependent effects on EC-coupling
in ventricular cardiomyocytes. At concentrations ≤2M,
2-APB did not have any apparent effect on electrically-evoked
Ca2+ transients (Fig. 10B). With 10M 2-APB, there was a
biphasic effect: a transient increase in the amplitude of sys-
tolic Ca2+ rises was followed by a progressive diminution
of the electrically-evoked responses (Fig. 10C). Concentra-
tions of 2-APB that were ≥50M caused a simple decline
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Fig. 6. The inhibition of SOC-mediated Ca2+ entry by 2-APB is use-dependent. Panel A shows the lack of effect of 2-APB on subsequent Ca2+ influx
if it is applied before activation of SOC. Panel C depicts the potent inhibition of SOC-mediated Ca2+ influx if 2-APB is applied after activation of
SOC. Panels B and D summarise data from the experiments illustrated in panels A and C, respectively (mean ± S.E.M. for at least 30 cells from three
independent experiments for each condition). The asterisk (∗) indicates significantly different from control (P < 0.05).
in the amplitude of the electrically-evoked Ca2+ transients,
until signals could no longer be generated (Fig. 10D and E).
4. Discussion
Since its introduction, 2-APB has been used in many stud-
ies to demonstrate the participation of InsP3Rs in intracellu-
lar signalling. The relatively low cost, rapid membrane per-
meability in some cell types and apparent lack of effect on
RyRs [10] makes it potentially more useful than other antag-
onists of InsP3-induced Ca2+ release such as xestospongins
or heparin. However, since the original study by Maruyama
et al. [9], it has become clear that 2-APB can affect multiple
processes involved in cellular Ca2+ homeostasis. Despite the
lack of specificity, it remains worthwhile characterising the
properties of 2-APB to investigate whether it has any utility
for investigating aspects of Ca2+ signalling.
The complete inhibition of Ca2+ mobilisation evoked by
the InsP3 ester (Fig. 1) indicates that 2-APB can readily
cross the plasma membrane of HeLa cells. 2-APB also gave
a rapid inhibition of histamine- and ATP-evoked Ca2+ sig-
nals (Figs. 2 and 3), although there was an unexpected dis-
crepancy in the ability of 2-APB to abrogate responses to
these two agonists. 2-APB was more effective in inhibiting
ATP-evoked Ca2+ signals than those generated by histamine.
With all ATP concentrations tested (1–100M), 100M
2-APB fully inhibited its effect (Fig. 3). However, in the
presence of 100M 2-APB, HeLa cells were able to respond
to submaximal histamine concentrations, which gave lesser
Ca2+ signals than a maximal ATP dose, albeit that the num-
ber of responsive cells and the amplitude of the Ca2+ signals
were reduced (Figs. 2 and 3E). The reason why 2-APB was
able to more effectively inhibit ATP-evoked Ca2+ signals
may be due to an additional antagonist effect on the puriner-
gic receptors. Alternatively, it may indicate that histamine
stimulates the production of additional Ca2+-releasing mes-
sengers in addition to InsP3, which are 2-APB insensitive.
The rapid on-set of inhibition by 2-APB contrasts with
its slow reversibility. Even after 5 min of continual perfu-
sion, histamine- and ATP-evoked Ca2+ responses did not
recover (Figs. 2 and 3). This long-lasting inhibition of Ca2+
signals was only apparent if 2-APB was applied during cell
stimulation. When given on its own, 2-APB had little ef-
fect on subsequent responses (Fig. 4), in keeping with a
‘use-dependent’ effect. Several previous studies have noted
a slow reversibility of 2-APB’s effects in the order of tens
of minutes [14,19–21], whilst others have demonstrated that
it reverses within a few minutes [17] or even immediately
[24].
We did not identify all the cellular sites in HeLa cells
to which 2-APB will bind and slowly reverse. However, it
is clear that it can bind to activated SOC channels (Figs. 5
and 6), and persist for several minutes (Fig. 5D). The pro-
C.M. Peppiatt et al. / Cell Calcium 34 (2003) 97–108 105
Fig. 7. 2-APB causes mitochondria to swell, but not change shape and inhibits Ca2+ uptake. The sequence of images in panel A show that mitochondria
retain their membrane potential during perfusion with 100M 2-APB. HeLa cells were loaded with TMRE as indicated in Section 2, and imaged with
a BioRad MRC1024 laser scanning confocal microscope (excitation 514 nm, emission 525LP). Images were acquired (i) before, (ii) 5 min after addition
of 100M 2-APB, and then (iii) 5 min, and (iv) 70 min after washout of 2-APB with fresh extracellular medium. 2-APB was left on the cells for 15 min
before washout. There is no loss of TMRE fluorescence at any stage, indicating that the mitochondria do not depolarise. Panel B shows a portion of
a HeLa cell before (i) and after (ii) perfusion with 100M 2-APB for 5 min. Cells were stained with Mitotracker Green FM (0.1M, 20 min) and
imaged with a BioRad MRC1024 laser scanning confocal microscope (excitation 488 nm, emission >500 nm). Panel C illustrates that mitochondrial Ca2+
sequestration is reduced by 100M 2-APB. Cells were loaded with Rhod-2 (1M; 30 min). Rhod-2 fluorescence was monitored in the nucleus and
mitochondria using a BioRad 1024 confocal microscope to provide a simultaneous measure of cytosolic and mitochondrial matrix Ca2+ concentration,
respectively (nuclear and cytosolic Ca2+ mirror each other in HeLa cells). The bars show the fold increase in Rhod-2 fluorescence over basal signal
(i.e. F/Fo) following application of 100M histamine. The data represent the averaged peak Rhod-2 signal± S.E.M. (n = 3). The asterisk (∗) indicates
significantly different from control (P < 0.05).
longed inhibition of SOC-mediated Ca2+ entry almost cer-
tainly contributed to the lack of recovery of histamine and
ATP-evoked Ca2+ signals after washout of 2-APB, as the
intracellular Ca2+ stores would not have fully recovered be-
tween agonist pulses (Fig. 8). It is plausible that 2-APB re-
verses slowly from InsP3Rs and SERCAs, and that this also
prevented the recovery of agonist responses.
The observation that 2-APB slowed the recovery of
Ca2+cyt transients caused by SOC-mediated Ca2+ entry
(Fig. 5E) indicated that it inhibited processes responsible
for restoring basal Ca2+ levels. It is known that 2-APB
can inhibit SERCA pumps [11,26]. However, in the exper-
iments shown in Fig. 5, the SERCA pumps were inhibited
by several minutes of perfusion with thapsigargin prior to
2-APB addition. The ability of 2-APB to reduce the rate of
recovery of Ca2+cyt signals in the presence of thapsigargin
indicated that it affected other Ca2+ removal mechanisms,
such as PMCAs and mitochondria. Clearly, 2-APB does
interact with mitochondria, since it cause them to swell
(Fig. 7A) and inhibits extrusion of Ca2+ [19]. Although it
did not evoke mitochondrial depolarisation (Fig. 7B), their
ability to sequester Ca2+ was reduced (Fig. 7C).
The effect on SERCA pumps probably caused the
run-down of the Ca2+ stores observed when 2-APB was
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Fig. 8. 2-APB inhibits the refilling of the intracellular Ca2+ pool. Panel A depicts the averaged response of HeLa cells to two pulses of 100M histamine
in Ca2+-containing extracellular medium (1 min application and 10 min washout) followed by addition of 10M ionomycin in Ca2+-free extracellular
medium to asses the relative size of the intracellular Ca2+ pool. Panel B depicts a similar experiment to that shown in panel A, except that 100M
2-APB was added 1 min before and during the second histamine application. For both panels A and B, the data represent mean± S.E.M. for at least 30
cells from three independent experiments.
Fig. 9. 2-APB causes the gradual depletion of intracellular Ca2+ stores.
The bars depict the normalised responses of HeLa cells to 10M ion-
omycin (applied in Ca2+ free medium) after incubation in Ca2+-free
medium without (open columns) or with (grey columns) 100M 2-APB.
The duration of pre-treatment with 2-APB prior to ionomycin addition is
shown beneath the columns. The data represent mean ± S.E.M. for the
ionomycin-evoked peak Ca2+ transient amplitude, with at least 30 cells
analysed for each time point.
applied on its own (Fig. 9). The ability of 100M 2-APB
to deplete ∼40% of the ionomycin-releasable Ca2+ pool
after only 1 min of incubation suggests that it dramatically
inhibits Ca2+ sequestration. This depletion of the intracel-
lular Ca2+ pool occurred in the absence of a detectable
Ca2+cyt rise. Clearly, 2-APB cannot be used as a diagnostic
for the involvement of InsP3Rs in the generation of cellu-
lar Ca2+ signals if it simply causes the passive release of
intracellular Ca2+ stores (Fig. 9).
An effect of 2-APB on SERCA pumps can explain the
progressive inhibition of EC-coupling in ventricular car-
diomyocytes (Fig. 10). The biphasic effect of 10M 2-APB
on the amplitude of the evoked Ca2+ signals most proba-
bly reflected an initially enhanced response due to incom-
plete Ca2+ sequestration following a depolarisation-evoked
Ca2+ signal, with the lack of Ca2+ store refilling eventu-
ally leading to a failure of EC-coupling. With the higher
concentrations of 2-APB, a more pronounced inhibition of
SERCAs would have caused the immediate run-down of
the Ca2+ stores and corresponding Ca2+cyt responses. Al-
though cardiac myocytes can produce InsP3 in response to
some inotropic stimuli [28], it is not thought to play any role
in normal EC-coupling. Furthermore, SOC is also not be-
lieved to play a significant role in ventricular cardiomyocyte
EC-coupling.
Given that 2-APB has so many intracellular targets, it
is important to consider if it has any significant use at all.
In a previous study, we used 2-APB to investigate whether
InsP3 mediated the inotropic or pro-arrhythmogenic effects
of endothelin on atrial myocytes. By empirically investi-
gating the effect of a range of 2-APB concentrations sim-
ilar to that shown in Fig. 10, we were able to find a dose
(2M) that did not affect EC-coupling, but could inhibit
responses to the InsP3 ester [28]. Therefore, in some cell
types adjusting the concentration of 2-APB may provide a
window of opportunity where the effect of 2-APB will be
relatively more specific for InsP3Rs over other processes in-
volved in Ca2+ handling. Furthermore, 2-APB may be use-
ful in distinguishing between different pathways of Ca2+
release and entry. We have observed that 2-APB does not
prevent Ca2+ release or Ca2+ influx stimulated by arachi-
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Fig. 10. 2-APB modulates Ca2+ transients during excitation
contraction-coupling. Isolated ventricular cardiomyocytes were incubated
with the concentrations of 2-APB shown on the individual panels (A–E)
and continuously electrically stimulated at 0.3 Hz (marked by arrowheads).
The electrically-evoked Ca2+ transients were recorded using ratiometric
Indo1 measurements (see Section 2). For each 2-APB concentration, the
effect of 2-APB was assessed by monitoring 10-s recordings of Indo1 flu-
orescence at the times indicated at the top of the figure. Between record-
ings, the electrical pacing was maintained, but the UV illumination of
Indo1 was removed to prevent photodamage or bleaching of the indicator.
donate (data not shown), consistent with observations us-
ing HEK-293 cells [32]. Several other non-voltage-activated
Ca2+ entry pathways that are distinct from SOC are also
not inhibited by 2-APB, including maitotoxin-evoked Ca2+
entry in hepatocytes [17], S-nitrosylation-induced influx in
a smooth muscle cell line [33], Ca2+ influx caused by di-
acylglycerol analogues in PC12 cells [34], muscarinic ac-
tivation of non-selective cation channels in smooth mus-
cle [35]. In many instances, 2-APB can be used to block
SOC-mediated Ca2+ influx, although it should be noted that
it is not completely specific for SOC [10]. The ability of
2-APB to penetrate into different cell types appears to vary
significantly [13]. This could explain the high sensitivity of
some cell types to 2-APB [36] and the lack of effect 2-APB
on InsP3-evoked Ca2+ release in others [37].
Clearly, 2-APB may be useful in probing different path-
ways of Ca2+ release and entry. For some cells, it is a rapidly
membrane-permeant blocker of InsP3Rs, and completely in-
hibits SOC-mediated Ca2+ influx. However, it is necessary
to rigorously investigate the effect that 2-APB has on Ca2+
homeostasis in the cells under examination. The prevention
of Ca2+ signals by 2-APB may not necessarily indicate a role
for InsP3Rs, since 2-APB can cause an imperceptible de-
pletion of intracellular Ca2+ stores. In addition, it can affect
other cellular processes, such as mitochondrial morphology,
which may indirectly alter cellular Ca2+ signalling. Further-
more, the effects of 2-APB may be difficult to reverse.
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